 |
| |
| 1. |
Zhang, Q.; Faca, V.; Hanash, S. (2011). Mining the plasma proteome for
disease applications across seven logs of protein abundance. J Proteome Res.
10, 46-50. [PubMed] |
| 2. |
Surinova, S.; Schiess, R.; Huttenhain, R.; Cerciello, F.; Wollscheid, B.;
Aebersold, R. (2011). On the development of plasma protein biomarkers. J
Proteome Res. 10, 5-16. [PubMed] |
| 3. |
Musilova, I.; Kacerovsky, M.; Tambor, V.; Tosner, J. (2011). [Proteomics
and biomarkers for detection of preterm labor: a systematic review]. Ceska
Gynekol. 76, 37-45. [PubMed] |
| 4. |
Tesch, G. H. (2010). Review: Serum and urine biomarkers of kidney disease:
A pathophysiological perspective. Nephrology (Carlton). 15, 609-616. [PubMed] |
| 5. |
Teng, P. N.; Bateman, N. W.; Hood, B. L.; Conrads, T. P. (2010). Advances
in proximal fluid proteomics for disease biomarker discovery. J Proteome
Res. 9, 6091-6100. [PubMed] |
| 6. |
Pasini, E. M.; Lutz, H. U.; Mann, M.; Thomas, A. W. (2010). Red blood cell
(RBC) membrane proteomics--Part I: Proteomics and RBC physiology. J Proteomics.
73, 403-420. [PubMed] |
| 7. |
Liumbruno, G.; D'Alessandro, A.; Grazzini, G.; Zolla, L. (2010). Blood-related
proteomics. J Proteomics. 73, 483-507. [PubMed] |
| 8. |
Leth-Larsen, R.; Lund, R. R.; Ditzel, H. J. (2010). Plasma membrane proteomics
and its application in clinical cancer biomarker discovery. Mol Cell Proteomics.
9, 1369-1382. [PubMed] |
| 9. |
Gaso-Sokac, D.; Josic, D. (2010). The role of proteomics in plasma fractionation
and quality control of plasma-derived therapeutic proteins. Blood Transfus.
8 Suppl 3, s86-91. [PubMed] |
| 10. |
Davidsson, P.; Hulthe, J.; Fagerberg, B.; Camejo, G. (2010). Proteomics
of apolipoproteins and associated proteins from plasma high-density lipoproteins.
Arterioscler Thromb Vasc Biol. 30, 156-163. [PubMed] |
| 11. |
Blennow, K.; Hampel, H.; Weiner, M.; Zetterberg, H. (2010). Cerebrospinal
fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 6, 131-144. [PubMed] |
| 12. |
Anderson, N. L. (2010). The clinical plasma proteome: a survey of clinical
assays for proteins in plasma and serum. Clin Chem. 56, 177-185. [PubMed] |
| 13. |
Garbett, N. C.; Mekmaysy, C. S.; Helm, C. W.; Jenson, A. B.; Chaires, J.
B. (2009). Differential scanning calorimetry of blood plasma for clinical
diagnosis and monitoring. Exp Mol Pathol. 86, 186-191. [PubMed] |
| 14. |
Paczesny, S.; Levine, J. E.; Braun, T. M.; Ferrara, J. L. (2009). Plasma
biomarkers in graft-versus-host disease: a new era? Biol Blood Marrow Transplant.
15, 33-38. [PubMed] |
| 15. |
Pernemalm, M.; Lewensohn, R.; Lehtio, J. (2009). Affinity prefractionation
for MS-based plasma proteomics. Proteomics. 9, 1420-1427. [PubMed] |
| 16. |
Song, F.; Poljak, A.; Smythe, G. A.; Sachdev, P. (2009). Plasma biomarkers
for mild cognitive impairment and Alzheimer's disease. Brain Res Rev. 61,
69-80. [PubMed] |
| 16 |
Manley, S. A.; Gailer, J. (2009). Analysis of the plasma metalloproteome
by SEC-ICP-AES: bridging proteomics and metabolomics. Expert Rev Proteomics.
6, 251-265. [PubMed] |
| 18. |
Apweiler, R.; Aslanidis, C.; Deufel, T.; Gerstner, A.; Hansen, J.; Hochstrasser,
D.; Kellner, R.; Kubicek, M.; Lottspeich, F.; Maser, E.; Mewes, H. W.; Meyer,
H. E.; Mullner, S.; Mutter, W.; Neumaier, M.; Nollau, P.; Nothwang, H. G.;
Ponten, F.; Radbruch, A.; Reinert, K.; Rothe, G.; Stockinger, H.; Tarnok,
A.; Taussig, M. J.; Thiel, A.; Thiery, J.; Ueffing, M.; Valet, G.; Vandekerckhove,
J.; Verhuven, W.; Wagener, C.; Wagner, O.; Schmitz, G. (2009). Approaching
clinical proteomics: current state and future fields of application in fluid
proteomics. Clin Chem Lab Med. 47, 724-744. [PubMed] |
| 19. |
Chiu, C. L.; Randall, S.; Molloy, M. P. (2009). Recent progress in selected
reaction monitoring MS-driven plasma protein biomarker analysis. Bioanalysis.
1, 847-855. [PubMed] |
| 20. |
Pisonero, J.; Gunther, D. (2008). Femtosecond laser ablation inductively
coupled plasma mass spectrometry: fundamentals and capabilities for depth
profiling analysis. Mass Spectrom Rev. 27, 609-623. [PubMed] |
| 21. |
Nissum, M.; Foucher, A. L. (2008). Analysis of human plasma proteins: a
focus on sample collection and separation using free-flow electrophoresis.
Expert Rev Proteomics. 5, 571-587. [PubMed] |
| 22. |
Zolla, L. (2008). Proteomics studies reveal important information on small
molecule therapeutics: a case study on plasma proteins. Drug Discov Today.
13, 1042-1051. [PubMed] |
| 23. |
de Roos, B. (2008). Proteomic analysis of human plasma and blood cells
in nutritional studies: development of biomarkers to aid disease prevention.
Expert Rev Proteomics. 5, 819-826. [PubMed] |
| 24. |
Merrick, B. A. (2008). The plasma proteome, adductome and idiosyncratic
toxicity in toxicoproteomics research. Brief Funct Genomic Proteomic. 7,
35-49. [PubMed] |
| 25. |
Dayarathna, M. K.; Hancock, W. S.; Hincapie, M. (2008). A two step fractionation
approach for plasma proteomics using immunodepletion of abundant proteins
and multi-lectin affinity chromatography: Application to the analysis of
obesity, diabetes, and hypertension diseases. J Sep Sci. 31, 1156-1166. [PubMed] |
| 26. |
Wildgruber, R.; Yi, J.; Nissum, M.; Eckerskorn, C.; Weber, G. (2008). Free-flow
electrophoresis system for plasma proteomic applications. Methods Mol Biol.
424, 287-300. [PubMed] |
| 27. |
Hanash, S. M.; Pitteri, S. J.; Faca, V. M. (2008). Mining the plasma proteome
for cancer biomarkers. Nature. 452, 571-579. [PubMed] |
| 28. |
Candiano, G.; Musante, L.; Petretto, A.; Bruschi, M.; Santucci, L.; Urbani,
A.; Scolari, F.; Gusmano, R.; Carraro, M.; Zennaro, C.; Vincenti, F.; Ghiggeri,
G. M. (2008). Proteomics of plasma and urine in primary nephrotic syndrome
in children. Contrib Nephrol. 160, 17-28. [PubMed] |
| 29. |
Gerszten, R. E.; Accurso, F.; Bernard, G. R.; Caprioli, R. M.; Klee, E.
W.; Klee, G. G.; Kullo, I.; Laguna, T. A.; Roth, F. P.; Sabatine, M.; Srinivas,
P.; Wang, T. J.; Ware, L. B. (2008). Challenges in translating plasma proteomics
from bench to bedside: update from the NHLBI Clinical Proteomics Programs.
Am J Physiol Lung Cell Mol Physiol. 295, L16-22. [PubMed] |
| 30. |
Liumbruno, G.; D'Amici, G. M.; Grazzini, G.; Zolla, L. (2008). Transfusion
medicine in the era of proteomics. J Proteomics. 71, 34-45. [PubMed] |
| 31. |
Sahab, Z. J.; Semaan, S. M.; Sang, Q. X. (2007). Methodology and applications
of disease biomarker identification in human serum. Biomark Insights. 2,
21-43. [PubMed] |
| 32. |
Meng, Z.; Veenstra, T. D. (2007). Proteomic analysis of serum, plasma,
and lymph for the identification of biomarkers. Proteomics Clin Appl. 1,
747-757. [PubMed] |
| 33. |
Drake, R. R.; Cazares, L.; Semmes, O. J. (2007). Mining the low molecular
weight proteome of blood. Proteomics Clin Appl. 1, 758-768. [PubMed] |
| 34. |
Vivanco, F.; Mas, S.; Darde, V. M.; De la Cuesta, F.; Alvarez-Llamas, G.;
Barderas, M. G. (2007). Vascular proteomics. Proteomics Clin Appl. 1, 1102-1122. [PubMed] |
| 35. |
Luque-Garcia, J. L.; Neubert, T. A. (2007). Sample preparation for serum/plasma
profiling and biomarker identification by mass spectrometry. J Chromatogr
A. 1153, 259-276. [PubMed] |
| 36. |
Kim, M. R.; Kim, C. W. (2007). Human blood plasma preparation for two-dimensional
gel electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 849,
203-210. [PubMed] |
| 37. |
Thiele, T.; Steil, L.; Volker, U.; Greinacher, A. (2007). Proteomics of
blood-based therapeutics: a promising tool for quality assurance in transfusion
medicine. BioDrugs. 21, 179-193. [PubMed] |
| 38. |
Barelli, S.; Crettaz, D.; Thadikkaran, L.; Rubin, O.; Tissot, J. D. (2007).
Plasma/serum proteomics: pre-analytical issues. Expert Rev Proteomics. 4,
363-370. [PubMed] |
| 39. |
Issaq, H. J.; Xiao, Z.; Veenstra, T. D. (2007). Serum and plasma proteomics.
Chem Rev. 107, 3601-3620. [PubMed] |
| 40. |
Lee, H. J.; Lee, E. Y.; Kwon, M. S.; Paik, Y. K. (2006). Biomarker discovery
from the plasma proteome using multidimensional fractionation proteomics.
Curr Opin Chem Biol. 10, 42-49. [PubMed] |
| 41. |
Rai, A. J.; Vitzthum, F. (2006). Effects of preanalytical variables on
peptide and protein measurements in human serum and plasma: implications
for clinical proteomics. Expert Rev Proteomics. 3, 409-426. [PubMed] |
| 42. |
Queloz, P. A.; Thadikkaran, L.; Crettaz, D.; Rossier, J. S.; Barelli, S.;
Tissot, J. D. (2006). Proteomics and transfusion medicine: future perspectives.
Proteomics. 6, 5605-5614. [PubMed] |
| 43. |
Hu, S.; Loo, J. A.; Wong, D. T. (2006). Human body fluid proteome analysis.
Proteomics. 6, 6326-6353. [PubMed] |
| 44. |
Schmidt, A.; Aebersold, R. (2006). High-accuracy proteome maps of human
body fluids. Genome Biol. 7, 242. [PubMed] |
| 45. |
Herosimczyk, A.; Dejeans, N.; Sayd, T.; Ozgo, M.; Skrzypczak, W. F.; Mazur,
A. (2006). Plasma proteome analysis: 2D gels and chips. J Physiol Pharmacol.
57 Suppl 7, 81-93. [PubMed] |
| 46. |
Rose, K. (2005). Industrial-scale proteomics analysis of human plasma.
Methods Biochem Anal. 45, 217-229. [PubMed] |
| 47. |
Veenstra, T. D.; Conrads, T. P.; Hood, B. L.; Avellino, A. M.; Ellenbogen,
R. G.; Morrison, R. S. (2005). Biomarkers: mining the biofluid proteome.
Mol Cell Proteomics. 4, 409-418. [PubMed] |
| 48. |
Plebani, M. (2005). Proteomics: the next revolution in laboratory medicine?
Clin Chim Acta. 357, 113-122. [PubMed] |
| 49. |
Lathrop, J. T.; Hayes, T. K.; Carrick, K.; Hammond, D. J. (2005). Rarity
gives a charm: evaluation of trace proteins in plasma and serum. Expert Rev
Proteomics. 2, 393-406. [PubMed] |
| 50. |
Thadikkaran, L.; Siegenthaler, M. A.; Crettaz, D.; Queloz, P. A.; Schneider,
P.; Tissot, J. D. (2005). Recent advances in blood-related proteomics. Proteomics.
5, 3019-3034. [PubMed] |
| 51. |
Jacobs, J. M.; Adkins, J. N.; Qian, W. J.; Liu, T.; Shen, Y.; Camp, D.
G., 2nd; Smith, R. D. (2005). Utilizing human blood plasma for proteomic
biomarker discovery. J Proteome Res. 4, 1073-1085. [PubMed] |
| 52. |
Taback, B.; Hoon, D. S. (2004). Circulating nucleic acids and proteomics
of plasma/serum: clinical utility. Ann N Y Acad Sci. 1022, 1-8. [PubMed] |
| 53. |
Tam, S. W.; Pirro, J.; Hinerfeld, D. (2004). Depletion and fractionation
technologies in plasma proteomic analysis. Expert Rev Proteomics. 1, 411-420. [PubMed] |
| 54. |
van Eijk, H. M.; Deutz, N. E. (2003). Plasma protein synthesis measurements
using a proteomics strategy. J Nutr. 133, 2084S-2089S. [PubMed] |
| 55. |
Bergquist, J.; Palmblad, M.; Wetterhall, M.; Hakansson, P.; Markides, K.
E. (2002). Peptide mapping of proteins in human body fluids using electrospray
ionization Fourier transform ion cyclotron resonance mass spectrometry. Mass
Spectrom Rev. 21, 2-15. [PubMed] |
| 56. |
Anderson, N. L.; Anderson, N. G. (2002). The human plasma proteome: history,
character, and diagnostic prospects. Mol Cell Proteomics. 1, 845-867. [PubMed] |
| 57. |
Liu, X.; Plasencia, M.; Ragg, S.; Valentine, S. J.; Clemmer, D. E. (2004).
Development of high throughput dispersive LC-ion mobility-TOFMS techniques
for analysing the human plasma proteome. Brief Funct Genomic Proteomic. 3,
177-186. [PubMed] |
| 58. |
Ossola, R.; Schiess, R.; Picotti, P.; Rinner, O.; Reiter, L.; Aebersold,
R. (2011). Biomarker validation in blood specimens by selected reaction monitoring
mass spectrometry of N-glycosites. Methods Mol Biol. 728, 179-194. [PubMed] |
| 59. |
Wang, H.; Hanash, S. (2009). Electrospray mass spectrometry for quantitative
plasma proteome analysis. Methods Mol Biol. 564, 227-242. [PubMed] |
| |
Farrah, T.; Deutsch, E. W.; Aebersold, R. (2011). Using the Human Plasma
PeptideAtlas to study human plasma proteins. Methods Mol Biol. 728, 349-374. [PubMed] |
| 60.
|
Serum/Plasma Proteomics: Methods and Protocols (Simpson RJ
and Greening DW, editors) (Humana Press) Methods in Molecular Biology 728
Springer Protocols. 2011 | ISSN 1064-3754 | ISBN 978-1-61779-067-6 | DOI
10.1007/978-1-61779-6 | Library of Congress Control Number: 2011923966 |
|
 |
